Latest Monoclonal antibodies Stories
LifeScienceIndustryResearch.com adds Latest Report on “Frontier Pharma: Psoriasis – Identifying and Commercializing First-in-Class Innovation” to its store. Dallas,
BREDA, The Netherlands and GHENT, Belgium, May 29, 2014 /PRNewswire/ -- arGEN-X will present full results from the dose-escalation part of a Phase 1 study of ARGX-110,
MONROVIA, Calif., May 28, 2014 /PRNewswire/ -- Xencor, Inc.
Protection Data Presented at the 17th Annual Meeting of the American Society of Gene & Cell Therapy BLUE BELL, Pa., May 27, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.
Scientists have found a way to target elusive cells that suppress immune response, depleting them with peptides that spare other important cells and shrink tumors in preclinical experiments.
LONDON, May 23, 2014 /PRNewswire/ -- New Company Created to be a Leading Provider of Technologies and Services to Enable Better Biopharmaceuticals
Scientists at Cold Spring Harbor Laboratory (CSHL) today report a discovery that they hope will lead to the development of a powerful new way of treating an aggressive form of breast cancer.
MONROVIA, Calif., May 22, 2014 /PRNewswire/ -- Xencor, Inc.
New comprehensive research report “Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapies”
- A political dynamiter.
More Images (1 images) »